Expression of the CTLA-4 Ligand CD86 on Plasmacytoid Dendritic Cells (pDC) Predicts Risk of Disease Recurrence After Treatment Discontinuation in CML
Leukemia - United Kingdom
doi 10.1038/leu.2017.348
Full Text
Open PDFAbstract
Available in full text
Date
January 30, 2018
Authors
Publisher
Springer Science and Business Media LLC